Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04160065
Title Immunotherapy With IFx-Hu2.0 Vaccine for Advanced MCC or cSCC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Morphogenesis, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field